Skip to content
Insider tapeFilings through Wed, Oct 28
My stocks
✦ Spy Mode investigation

Troy A. Ignelzi's $144K purchase of RAPP

Rapport Therapeutics, Inc. · CFO · filed Oct 21, 2026. Opened Oct 28, 2026, last checked Oct 28, 2026. 7-day result in; next check Nov 20, 2026.

Reported value$144K5,500 shares at $26.10
For this personUnusual1 buy · 0 sales on file
Similar buys beat S&P47%176 cases · all buys 46%

Worth a closer look

  • Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
  • Bought by the CFO, one of the two people with the fullest view of the company.
  • Raised their own holding by 55%.
  • 6 different insiders bought in the last 90 days.

Reasons for caution

  • Other insiders sold $6.9M in the same 90 days, more than was bought (100% of it pre-planned).
  • Similar past buys beat the S&P 500 only 47% of the time (176 cases); the typical one trailed it by 1.3%.

What happened after this filing

7 days -10.2% -10.1% vs S&P
30 days Pending due Nov 20
90 days Pending due Jan 19

What we couldn't check

  • Why they traded. Filings don't say, and we don't guess.
  • Company news after the filing, and any private terms.
Summary

Troy A. Ignelzi (CFO) bought $144K of RAPP at about $26.10 on Oct 21, 2026, reported to the SEC on Oct 21, 2026. Buys like this beat the S&P 500 47% of the time since 2020, against 46% for all insider buys. We found 4 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.

Share on X Bluesky Reddit

Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.

Other RAPP insider trades

Get RAPP insider alerts

Choose what you want to hear about. Free.

You'll get an email when a new RAPP filing matches your choices (at most one per alert type a day), plus the free Monday email. Already subscribed? Use the same email to add RAPP. Unsubscribe anytime. No price targets or advice.

More investigations

All →